A multicenter-retrospective study of non-small-cell lung carcinoma harboring uncommon epidermal growth factor receptor (EGFR) mutations: different subtypes of EGFR exon 19 deletion-insertions exhibit the clinical characteristics and prognosis of non-small cell lung carcinoma.
YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics.
Proceedings Of The National Academy Of Sciences Of The United States Of America
Fan, Pang-Dian PD; Narzisi, Giuseppe G; Jayaprakash, Anitha D AD; Venturini, Elisa E; Robine, Nicolas N; Smibert, Peter P; Germer, Soren S; Yu, Helena A HA; Jordan, Emmet J EJ; Paik, Paul K PK; Janjigian, Yelena Y YY; Chaft, Jamie E JE; Wang, Lu L; Jungbluth, Achim A AA; Middha, Sumit S; Spraggon, Lee L; Qiao, Huan H; Lovly, Christine M CM; Kris, Mark G MG; Riely, Gregory J GJ; Politi, Katerina K; Varmus, Harold H; Ladanyi, Marc M